- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-03-0036370

Wevet Pharmaceuticals Private Limited
About Wevet Pharmaceuticals Private Limited
Data last updated:
Wevet Pharmaceuticals Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 03 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2019PTC111895. Its GSTIN is 09AACCW3451A1ZN (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Priyanka Shukla and Savitri.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 98F/2 Anand Nagar Naini, Allahabad, Uttar Pradesh, India – 211008.
As per the financials filed for FY 2024, the company reported a revenue of ₹42.84 Lakh, a growth of 69% compared to the previous year. For the same year it recorded a net profit of ₹25,779 (net margin 0.6%) and EBITDA of ₹25,779 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
Wevet Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-03-0036370).
Company details
Recognitions & Rankings of Wevet Pharmaceuticals
Contact details
Wevet Pharmaceuticals Private Limited's registered office is in Allahabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address98F/2 Anand Nagar Naini, Allahabad, Uttar Pradesh, India – 211008
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Wevet Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wevet Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Wevet Pharmaceuticals Private Limited, buy the company report.
Financials of Wevet Pharmaceuticals Private Limited
FY 2024 filings availableWevet Pharmaceuticals Private Limited reported revenue of ₹42.84 Lakh (up 69% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 69% growth in the latest year. EBITDA rose 173% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25,779 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25,779 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wevet Pharmaceuticals Private Limited, buy the company report.
Board of directors of Wevet Pharmaceuticals Private Limited
Wevet Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Shukla | Director | 03 Jan 2019 | 7 Years 10 Months | Current |
| Savitri | Director | 03 Jan 2019 | 7 Years 10 Months | Current |
Peer comparison
Wevet Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SMV Pharmaceuticals Private Limited | ₹42.95 Lakh (FY 2025) | 2.0% | Chandigarh, India | |||
| Arlics Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2025) | 1.0% | Mehsana, Gujarat, India | |||
| Torrey Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2024) | 116.0% | Nagpur, Maharashtra, India | |||
| Denexo Pharmaceuticals Private Limited | ₹42.9 Lakh (FY 2025) | 4.0% | Kharghar, Maharashtra, India | |||
| Trumedis Pharmaceuticals Private Limited | ₹42.85 Lakh (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Wevet Pharmaceuticals Private Limitedthis company | ₹42.84 Lakh (FY 2024) | ₹25,779 | 0.6% | 69.0% | Allahabad, Uttar Pradesh, India |
To see the full peer comparison of Wevet Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wevet Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wevet Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wevet Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCW3451A1ZN | Uttar Pradesh | Active | 28 Jun 2019 |
To see the full GST registrations and return filing status of Wevet Pharmaceuticals Private Limited, buy the company report.
Recent activity
Wevet Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Priyanka Shukla was appointed as Director on 03 Jan 2019.
Frequently asked questions
Wevet Pharmaceuticals is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 03 January 2019 (7+ years old) and is registered under CIN U51909UP2019PTC111895.
Wevet Pharmaceuticals has 2 current directors:
- Priyanka Shukla - Director
- Savitri - Director
The latest financial statements of Wevet Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Wevet Pharmaceuticals is 09AACCW3451A1ZN, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Wevet Pharmaceuticals is U51909UP2019PTC111895. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wevet Pharmaceuticals was incorporated on 03 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Wevet Pharmaceuticals by revenue are SMV Pharmaceuticals Private Limited, Arlics Pharmaceuticals Private Limited, Torrey Pharmaceuticals Private Limited, Denexo Pharmaceuticals Private Limited, Trumedis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Priyanka Shukla was appointed as Director on 03 Jan 2019. Savitri was appointed as Director on 03 Jan 2019.
Yes, Wevet Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-03-0036370).
The registered office of Wevet Pharmaceuticals is at 98F2 Anand Nagar Naini, Allahabad, Uttar Pradesh, India – 211008.
Wevet Pharmaceuticals operates in the trading industry, in the specialty segment.

